Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Return on Capital Employed (2021 - 2025)

Historic Return on Capital Employed for Biofrontera (BFRI) over the last 5 years, with Q3 2025 value amounting to 3.37%.

  • Biofrontera's Return on Capital Employed fell 12200.0% to 3.37% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.37%, marking a year-over-year decrease of 12200.0%. This contributed to the annual value of 1.32% for FY2024, which is 2600.0% down from last year.
  • Per Biofrontera's latest filing, its Return on Capital Employed stood at 3.37% for Q3 2025, which was down 12200.0% from 12.33% recorded in Q2 2025.
  • Over the past 5 years, Biofrontera's Return on Capital Employed peaked at 12.33% during Q2 2025, and registered a low of 3.37% during Q3 2025.
  • For the 5-year period, Biofrontera's Return on Capital Employed averaged around 0.47%, with its median value being 1.31% (2024).
  • Data for Biofrontera's Return on Capital Employed shows a peak YoY increase of 137100bps (in 2025) and a maximum YoY decrease of -12200bps (in 2025) over the last 5 years.
  • Over the past 5 years, Biofrontera's Return on Capital Employed (Quarter) stood at 1.23% in 2021, then skyrocketed by 53bps to 0.58% in 2022, then tumbled by -203bps to 1.75% in 2023, then decreased by -18bps to 2.08% in 2024, then plummeted by -62bps to 3.37% in 2025.
  • Its last three reported values are 3.37% in Q3 2025, 12.33% for Q2 2025, and 1.94% during Q1 2025.